The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial
出版年份 2018 全文链接
标题
The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial
作者
关键词
Osteoporosis, Adverse events, Bone density, Bone fracture, Bone resorption, Rheumatoid arthritis, Tuberculosis, Glucocorticoid therapy
出版物
PLoS One
Volume 13, Issue 3, Pages e0193846
出版商
Public Library of Science (PLoS)
发表日期
2018-03-16
DOI
10.1371/journal.pone.0193846
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
- (2017) Masato Sawamura et al. INTERNAL MEDICINE
- Infections in De Novo Kidney Transplant Recipients Treated With the RANKL Inhibitor Denosumab
- (2017) Marco Bonani et al. TRANSPLANTATION
- Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial
- (2015) Chi Chiu Mok et al. BONE
- Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update
- (2014) Yasuo Suzuki et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Glucocorticoid-induced osteoporosis: who to treat with what agent?
- (2014) René Rizzoli et al. Nature Reviews Rheumatology
- Prevention of Glucocorticoid-Induced Osteoporosis in Immunobullous Diseases With Alendronate
- (2011) Shang-Ian Tee ARCHIVES OF DERMATOLOGY
- Alendronate Adherence and Its Impact on Hip-Fracture Risk in Patients With Established Osteoporosis in Taiwan
- (2011) T-C Lin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Bone remodeling in postmenopausal women who discontinued denosumab treatment: Off-treatment biopsy study
- (2011) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Glucocorticoid-Induced Bone Disease
- (2011) Robert S. Weinstein NEW ENGLAND JOURNAL OF MEDICINE
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
- (2010) Alan L. Burshell et al. BONE
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
- (2009) R. K. Dore et al. ANNALS OF THE RHEUMATIC DISEASES
- Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells
- (2009) Lorenz C. Hofbauer et al. MOLECULAR ENDOCRINOLOGY
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started